Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency

OBJECTIVE: Patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease have an increased risk of micro- and macrovascular disease, but limited options for antihyperglycemic therapy. We compared the efficacy and safety of sitagliptin with glipizide in patients with T2DM and moderate-to-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Arjona Ferreira, Juan Camilo, Marre, Michel, Barzilai, Nir, Guo, Hua, Golm, Gregory T., Sisk, Christine McCrary, Kaufman, Keith D., Goldstein, Barry J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631833/
https://www.ncbi.nlm.nih.gov/pubmed/23248197
http://dx.doi.org/10.2337/dc12-1365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631833/
https://www.ncbi.nlm.nih.gov/pubmed/23248197
http://dx.doi.org/10.2337/dc12-1365

Ejemplares similares